The CIPHIA (Côte d'Ivoire Population-based HIV Impact Assessment) survey has resumed, with final report availability expected by the end of September 2025.

Paediatric and syrup formulations: Zidovudine/Lamivudine tablet stock is high (25.27 months of stock). Nevirapine syrup is fully available (6.38 MoS), there are lower stock levels of Zidovudine syrup ...